Infection Blood Articles & Analysis
-
Specific Diagnostics Commences US Clinical Trials for FDA 510(k) Clearance of its Reveal Rapid AST System
Specific Diagnostics announces today the commencement of its US clinical studies for the Reveal Rapid AST System for blood infection. Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the Reveal test. In Europe, where the Reveal is launched under CE-IVD registration, 11 studies across France and England comprising over 1,400 ...
-
S.F.-based startup raises $25M to expand blood collection technologies
San Francisco medical device company Velano Vascular closed a $25 million second round of financing, bringing its total overall to $50 million. The new capital will go toward expanding its needle-less blood draw device and to developing new technologies. CEO Eric Stone would not reveal what these new technologies will entail but said they will fall within the company’s mission ...
-
Specific Diagnostics Announces the Formation of its US Commercial Team and Introduction of the Reveal Rapid AST System to the US Market
Specific Diagnostics today announced formation of its US commercial sales, service, support and marketing teams in anticipation of the launch of the Reveal Rapid AST System for blood infection samples. Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, and in tandem with the commencement of clinical and ...
-
Linear Health Sciences Receives Grant to Work with Global Center for Medical Innovation
OKLAHOMA CITY, Oklahoma – Linear Health Sciences, developer of the Orchid™ Safety Release Valve (SRV), announced that it has received a substantial grant to work with the Global Center for Medical Innovation. GCMI is a comprehensive medical-device innovation center that guides the development and commercialization of new medical devices. Linear Health Sciences is the first company to ...
-
IV Dislodgement Is a Common Problem in Vascular Access, Clinicians Say
Portsmouth, N.H. – IV dislodgement is a near-daily problem for clinicians and their patients, according to a recent focus group of vascular access experts. The clinicians also reported there is a need for better technology to mitigate the potentially serious consequences of frequent IV dislodgements. “This research discussion addressed a frustrating problem that those of us in ...
-
Former Genmark Senior Vice President Scott O’Brien Joins Specific Diagnostics as Chief Commercial Officer
Specific Diagnostics today announced the appointment of Scott O’Brien as its Chief Commercial Officer. Mr. O’Brien is an industry veteran with over 20 years in molecular and infectious disease diagnostics, the last 10 at GenMark where he held a range of commercial positions, most recently Senior Vice President Global Marketing and International Sales at GenMark Diagnostics, ...
-
New Tickborne Disease Website Launched by EMSL Analytical, Inc.
The Centers for Disease Control and Prevention (CDC) report that in 2010 more than 22,000 confirmed cases and 7,500 probable cases of Lyme disease were reported to the agency. Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans through the bite of infected ticks. Typical symptoms include fever, headache, fatigue and a characteristic skin rash called ...
-
Linear Health Sciences’ Early Success Highlighted at SEMDA Medical Device Conference
ATLANTA, Georgia – The early success of Linear Health Sciences in developing its Orchid™ Safety Release Valve to prevent unwanted dislodgement of IV catheters was highlighted in a panel discussion at the recent annual conference of the Southeastern Medical Device Association (SEMDA). Dan Clark, co-founder and Chief Marketing Officer of Linear Health Sciences, represented the company ...
-
Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens
The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...
-
Infection Control Resources in Puerto Rico to Identify Acinetobacter and Other Microbial Pathogens
Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Infections of the blood, urinary tract and lungs, or in wounds in other parts of the body can all be caused by ...
-
Specific Diagnostics Announces the Results of Two Studies at Hospitals Within AP-HP (Assistance Publique-Hopitaux de Paris) Evaluating Performance of the Reveal Rapid AST System
Specific Diagnostics today announced results from two studies conducted in the Paris Teaching Hospital System (Assistance Publique-Hôpitaux Paris, AP-HP), Europe’s largest hospital network, reporting performance of the Reveal rapid antibiotic susceptibility testing (AST) system. Both studies, which comprised approximately 225 samples in total, found the same levels of accuracy ...
-
Cytovale Receives Distinguished Abstract Award from AACC for Evaluation of Sepsis Assay
Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics using cell mechanics and machine learning, has received an AACC Academy’s Distinguished Abstract Award for its abstract titled “Rapidly Assessing the Host Immune Response for the Diagnosis of Sepsis, a Prospective Multi-Site Clinical Study in the Emergency Department (ED) Employing the Leukocyte ...
-
Infection Control Resources to Mitigate Exposure Risks to Acinetobacter and Other Environmental Pathogens
Acinetobacter is described by the Centers for Disease Control and Prevention (CDC) as a group of bacteria commonly found in the environment. While there are many types, the most frequent cause of infections in humans is Acinetobacter baumannii. Infections of the blood, urinary tract, and lungs, or in wounds in other parts of the body can all be caused by Acinetobacter baumannii. It can also ...
-
HORIBA acquired 10,000m2 site for new reagent plant in Brazil
Production capacity of hematology reagents is to be doubled Handle expansion in medical services driven by economic growth HORIBA Group's local subsidiary in Brazil, HORIBA ABX Ltda. (1), acquired a 10,000 m2 site(2) on the outskirts of Sao Paolo, Brazil, and will construct a plant there for the manufacture of hematology reagents(3) for hospitals where hematology analyzers are used. The intent ...
-
New Accelerate Pheno Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021
In Patients Who Receive Ineffective Empirical Antibiotics for Blood Stream Infections (BSI), Use of AXDX Was Associated With Reduction in 30-Day Mortality Interim Data From Multicenter Study Highlight the Real-World Clinical Utility of Fast Phenotypic Antimicrobial Susceptibility Testing for BSI Across Diverse Healthcare Settings and Patient Populations Accelerate Diagnostics, Inc. ...
-
UroGen Announces Data that Shows In-Office Nephrostomy Tube Administration of Jelmyto® is Efficient for Doctors and Well Tolerated by Patients
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to creating novel solutions that treat urothelial and specialty cancers, today announced the first published report of real-world experience utilizing the antegrade approach for Jelmyto® (mitomycin) for pyelocalyceal solution administration in the Journal of Urology online on February 7, 2022. This report provides a stepwise ...
-
New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System
Inflammatix, a pioneering molecular diagnostics company delivering precision medicine at the point of care, announced findings from a new study published today in Nature Communications that demonstrate its ability to identify patients with bacterial versus viral infections using a data-driven approach that measures the immune system response. The molecular classifier used in the study forms the ...
-
Magnolia Medical Announces Expansion of Its Extensive Clinical Evidence Library with Six Steripath® ISDD® Studies in 2021 Demonstrating Zero or Near-Zero False Positive Sepsis Test Results
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced that six studies, reporting zero or near-zero blood culture contamination rates and up to a 31% reduction in vancomycin days of therapy (DOT) using Steripath, were submitted, accepted and published in ...
-
Novel Securement Device Making Inroads
AVA Scientific Meeting 2019 highlights key opportunities for improvement in vascular access from process bundles to emerging new products Introduction Acknowledgment of the importance of the vascular access nurse and team were obvious at this year’s Association for Vascular Access (AVA) Annual Scientific meeting. When Ramzy Nasrallah took over as CEO for the Association of Vascular Access ...
-
Candidiasis Infections Impact Midwest Healthcare Facilities
Candidiasis is caused by fungal pathogens from the Candida genus. Most infections are caused by Candida albicans, a type of fungus that grows both as a yeast and filamentous cells. The ubiquitous fungi represent one of the most common fungal pathogens to affect the human population. According to the Centers for Disease Control and Prevention (CDC), “Invasive candidiasis is a fungal ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you